Clinical Trial

Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure

Study acronym: SVALBARD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Acute hypoxemic respiratory failure may progress to acute respiratory distress syndrome, a life-threatening condition that often requires mechanical ventilation. The optimal ventilation strategy in this patient population remains uncertain. The SVALBARD trial is a feasibility and pilot study designed to compare spontaneous versus controlled mechanical ventilation in patients with acute hypoxemia respiratory failure. The primary objective is to assess the feasibility of the study procedures and interventions, while also collecting descriptive data on key clinical variables to inform the design of a future randomized controlled trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-05.
Trial Details
NCT Number NCT07463885
Lead Sponsor Oslo University Hospital
Collaborators: Rigshospitalet, Denmark, Aalborg University Hospital
Conditions Acute Respiratory Distress Syndrome (ARDS), Acute Hypoxemic Respiratory Failure
Enrollment 80 participants
Start Date 2026-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-13